NEAT1 and cancer: For instance, it identifies NEAT1-related SNV–ceRNA events as potential targets by linking them to cancer hallmarks (e.g. genomic instability) and drug sensitivity (e.g. NEAT1 enhancing HGSOC’s response to Olaparib).